Inhaled nitric oxide in primary pulmonary hypertension
A safe and effective agent for predicting response to nifedipine
Mark J. Ricciardi, MDa,
Bradley P. Knight, MDa,
Fernando J. Martinez, MDb and
Melvyn Rubenfire, MD, FACCa
a Division of Cardiology, University of Michigan, Ann Arbor, Michigan, USA
b Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan, USA

View larger version (14K):
[in a new window]
|
Figure 1 A plot of the reduction in pulmonary vascular resistance (PVR) with NO and nifedipine is shown. The three patients with nifedipine hypotension were assigned PVR reduction of 0% (i.e., fixed PVR).
|
|
|